Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oleogel-S10 versus moist wound dressing for split-thickness skin graft donor-site healing
2009-017418-56Phase 2Completed
- Sponsor
- Birken AG
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Birch bark extract in cutaneous wound (2 arms), sponsored by Birken AG. Primary endpoints: Wound re-epithelialization, Size of wound epithelialization and 1 more. Started Jan 2010; status: completed.
02
Drugs
Birch bark extract
03
Conditions
cutaneous wound
Beyond the preview
Go deeper on 2009-017418-56.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017418-56.